Shares ofAnika Therapeutics Inc(NASDAQ:ANIK), a small-cap biotech focused on regenerativemedicine, were down 36% as of 11:10 a.m. EDT on Tuesday. The stock plummetedafter the company reported data from an important phase 3 study.
Headlines about Spherix (NASDAQ:SPEX) have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale
A Wynn casino and hotel project set to open in Boston in 2019 has drawn the scrutiny of regulators following a Wall Street Journal story that detailed sexual misconduct allegations against founder and CEO Steve Wynn.
The Massachusetts Gaming Commission said it is reviewing a license it issued for a resort casino to Wynn Resorts.
“The Commission is now aware of and is taking....More>>>
Mention the word uranium and most likely weapons of mass destruction come to mind. While you can make plenty of jokes about investment returns in the event of nuclear war, choosing to diversify your portfolio with uranium mining stocks is certainly worth a closer look.
Azincourt Uranium Inc. (OTCBB: AZURF) (TSX: AAZ.V) the Canadian based resource company specializing....More>>>
In Intel’s (NASDAQ:INTC) most recent quarter, the company reported some interesting results for its Data Center Group (DCG) business, which supplies processors and other components for use in applications such as cloud and enterprise servers and networking appliances, among others.
Intel’s 10-core Ivy Bridge server processor. Image source: Intel.
On Tuesday, voters in California, Maine, Massachusetts and Nevada passed measures to legalize recreational marijuana good news for more well known marijuana stocks like GW Pharmaceuticals PLC (NASDAQ: GWPH)and Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE), Cannabis Science Inc (OTCMKTS: CBIS) and Medical Marijuana Inc (OTCMKTS: MJNA), but especially for small cap Lexaria Bioscience Corp (OTCQB: LXRP).....More>>>
It would be fair to say biotech has had an interesting time of it over the course of the past 15 months. Except, of course, that biotech always has an interesting time of it. The go big or go home sector of the market attracts speculators, scientists, and unsavory characters, but also attracts people hoping for critical improvements to their healthcare options.
What a silly stock market. There I was on Tuesday at 2:00 p.m. waiting for the Dow Jones Industrial Average to crash 1,700 points as Trump verbally ripped Iran to shreds (and pulled out of the Iran deal). The Dow instantly tanked 80 points one sentence into Trump’s latest global spectacle. But then the Blue Chip index rallied back as Trump continued to hit Iran, and actually finished the....More>>>
Tax reform has led to massive cash savings for corporate entities of all sizes. Those massive cash savings have fueled a red-hot M&A market, and an even hotter rumored M&A market. It seems every analyst keeps throwing their biggest and best M&A idea out there. Then, another acquisition happens, and more M&A rumors pop up.
Most recently, Media Tech Capital Partners’ Porter....More>>>
The title of this article may generate strong responses from some, who will reply: “never!” And indeed, if a value trap is defined as a stock that is not a value, then clearly a value trap is never a value. (There aren’t many rich dialetheists on Wall Street.) But let’s take a more nuanced view of a value trap and follow Investopedia.com in defining a value trap, which I....More>>>
Want to provide a health benefit to workers and encourage employees to save at the same time? Offer a high-deductible health plan combined with a health-savings account; it accomplishes both goals and likely encourages retention, too.
This sounds like Im mixing apples and oranges, but hear me out.
Founders at startups often agonize over retirement plans for employees. Not everyone....More>>>
When Amgen Inc. (NASDAQ: AMGN) reported its third-quarter financial results after the markets closed on Thursday, the company said that it had $3.02 in earnings per share (EPS) and $5.81 billion in revenue. Consensus estimates from Thomson Reuters had called for $2.79 in EPS and revenue of $5.74 billion. In the same period of last year, the biotech giant posted EPS of $2.72 and $5.72 billion in....More>>>
Wealthstreet Investment Advisors LLC cut its stake in Cisco Systems, Inc. (NASDAQ:CSCO) by 1.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 131,935 shares of the network equipment provider’s stock
So far this year Boeing (BA) is having a strong start looking at its financial results, but also when looking at the order book the jet maker is seeing some appreciable order inflow. One of the programs that could use some order inflow to avoid a further cut in production is the Boeing 777 progr
Being a member of the esteemed Dow Jones industrial average index is supposed to come with prestige. After all, there are only 30 companies at a time that can actually be a Dow stock. These companies are supposed to represent a major portion of the industrial business climate or to dominate a ma
Gatorade Zero, a thirst quencher without sugar or carbs, hit stores around the country this week. It comes in orange, lemon lime, and glacier cherry, and is priced in line with the brand's classic sports drink.
United Technologies Co. (NYSE:UTX) has been given a consensus recommendation of “Buy” by the twenty research firms that are covering the stock, Marketbeat.com reports. Seven analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Th